Last reviewed · How we verify
Vedrop (TOCOFERSOLAN)
Vedrop, also known as tocofersolan, is a small molecule drug that targets glutathione S-transferase P. It is used to treat obstruction of bile duct and vitamin E deficiency. The commercial status of Vedrop is currently unknown, and it is not clear if it is patented or available as a generic. Vedrop's safety considerations are also not well-documented. Further research is needed to fully understand its pharmacological properties and clinical applications.
At a glance
| Generic name | TOCOFERSOLAN |
|---|---|
| Target | Alpha-tocopherol transfer protein, Glutathione S-transferase P |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 2009 |
Approved indications
- Obstruction of bile duct
- Vitamin E deficiency
Common side effects
- Allergic sensitization
- Fatigue
Key clinical trials
- Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention (PHASE3)
- Surgiphor vs Saline Joints (NA)
- A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects (NA)
- Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy (PHASE2)
- Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS (NA)
- Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED (NA)
- Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children (PHASE2)
- A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vedrop CI brief — competitive landscape report
- Vedrop updates RSS · CI watch RSS